Gradient Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-230
| Closed | -$53.3K | – | 392 |
|
|
2024
Q2 | $53.3K | Hold |
230
| – | – | ﹤0.01% | 489 |
|
|
2024
Q1 | $49.6K | Hold |
230
| – | – | ﹤0.01% | 433 |
|
|
2023
Q4 | $59.5K | Hold |
230
| – | – | ﹤0.01% | 510 |
|
|
2023
Q3 | $59.1K | Hold |
230
| – | – | ﹤0.01% | 470 |
|
|
2023
Q2 | $65.5K | Hold |
230
| – | – | ﹤0.01% | 459 |
|
|
2023
Q1 | $63.9K | Hold |
230
| – | – | ﹤0.01% | 450 |
|
|
2022
Q4 | $63.7K | Hold |
230
| – | – | ﹤0.01% | 451 |
|
|
2022
Q3 | $61K | Hold |
230
| – | – | ﹤0.01% | 441 |
|
|
2022
Q2 | $47K | Sell |
230
-2
| -0.9% | -$409 | ﹤0.01% | 487 |
|
|
2022
Q1 | $49K | Hold |
232
| – | – | ﹤0.01% | 481 |
|
|
2021
Q4 | $56K | Hold |
232
| – | – | ﹤0.01% | 461 |
|
|
2021
Q3 | $66K | Hold |
232
| – | – | ﹤0.01% | 439 |
|
|
2021
Q2 | $80K | Hold |
232
| – | – | ﹤0.01% | 403 |
|
|
2021
Q1 | $65K | Sell |
232
-3
| -1% | -$809 | ﹤0.01% | 425 |
|
|
2020
Q4 | $67K | Hold |
235
| – | – | ﹤0.01% | 358 |
|
|
2020
Q3 | $67K | Buy |
235
+3
| +1% | +$837 | ﹤0.01% | 361 |
|
|
2020
Q2 | $62K | Sell |
232
-8
| -3% | -$2.4K | ﹤0.01% | 356 |
|
|
2020
Q1 | $76K | Sell |
240
-6
| -2% | -$1.82K | ﹤0.01% | 302 |
|
|
2019
Q4 | $73K | Sell |
246
-4
| -2% | -$1.11K | ﹤0.01% | 339 |
|
|
2019
Q3 | $58K | Buy |
250
+20
| +9% | +$4.66K | ﹤0.01% | 358 |
|
|
2019
Q2 | $54K | Hold |
230
| – | – | ﹤0.01% | 368 |
|
|
2019
Q1 | $54K | Hold |
230
| – | – | ﹤0.01% | 327 |
|
|
2018
Q4 | $69K | Sell |
230
-4
| -2% | -$1.28K | ﹤0.01% | 305 |
|
|
2018
Q3 | $83K | Hold |
234
| – | – | ﹤0.01% | 300 |
|
|
2018
Q2 | $68K | Hold |
234
| – | – | ﹤0.01% | 302 |
|
|
2018
Q1 | $64K | Hold |
234
| – | – | ﹤0.01% | 312 |
|
|
2017
Q4 | $75K | Buy |
+234
| New | +$75.1K | ﹤0.01% | 306 |
|
|
2017
Q3 | – | Sell |
-255
| Closed | -$69K | – | 274 |
|
|
2017
Q2 | $69K | Hold |
255
| – | – | ﹤0.01% | 284 |
|
|
2017
Q1 | $70K | Hold |
255
| – | – | 0.01% | 284 |
|
|
2016
Q4 | $72K | Sell |
255
-91
| -26% | -$27K | 0.01% | 236 |
|
|
2016
Q3 | $108K | Hold |
346
| – | – | 0.01% | 209 |
|
|
2016
Q2 | $84K | Sell |
346
-18
| -5% | -$4.74K | 0.01% | 223 |
|
|
2016
Q1 | $95K | Hold |
364
| – | – | 0.01% | 211 |
|
|
2015
Q4 | $112K | Hold |
364
| – | – | 0.01% | 202 |
|
|
2015
Q3 | $106K | Hold |
364
| – | – | 0.02% | 193 |
|
|
2015
Q2 | $147K | Buy |
364
+7
| +2% | +$2.81K | 0.02% | 181 |
|
|
2015
Q1 | $151K | Buy |
357
+18
| +5% | +$7.09K | 0.02% | 176 |
|
|
2014
Q4 | $115K | Sell |
339
-19
| -5% | -$6.15K | 0.02% | 182 |
|
|
2014
Q3 | $118K | Hold |
358
| – | – | 0.02% | 171 |
|
|
2014
Q2 | $113K | Buy |
358
+128
| +56% | +$38.5K | 0.02% | 175 |
|
|
2014
Q1 | $70K | Sell |
230
-33
| -13% | -$10.5K | 0.02% | 182 |
|
|
2013
Q4 | $74K | Hold |
263
| – | – | 0.02% | 197 |
|
|
2013
Q3 | $63K | Sell |
263
-230
| -47% | -$51.5K | 0.02% | 168 |
|
|
2013
Q2 | $106K | Buy |
+493
| New | +$105K | 0.04% | 128 |
|
Other funds holding BIIB
Gradient Investments's BIIB Position: Q3 2024 in Review
Gradient Investments sold out of Biogen (BIIB) in Q3 2024, closing a stake of 230 shares — an estimated $53.3K sold.
Gradient Investments first reported a position in BIIB in Q2 2013 and held it in 44 quarters. The position peaked at $151K in Q1 2015. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.
- Gradient Investments reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
- Gradient Investments sold 230 Biogen shares in Q3 2024, an estimated $53.3K.
- Gradient Investments first reported a position in Biogen in Q2 2013 and held it in 44 quarters.
- Gradient Investments's Biogen position peaked at $151K in Q1 2015.
- 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.
Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.